These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 33814802
1. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N. J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802 [Abstract] [Full Text] [Related]
2. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women. Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C. Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365 [Abstract] [Full Text] [Related]
3. Improved abnormal Pap smear triage using cervical cancer biomarkers. Killeen JL, Dye T, Grace C, Hiraoka M. J Low Genit Tract Dis; 2014 Jan 01; 18(1):1-7. PubMed ID: 23760145 [Abstract] [Full Text] [Related]
4. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group. Cancer Cytopathol; 2015 Jun 01; 123(6):373-81. PubMed ID: 25891096 [Abstract] [Full Text] [Related]
5. Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors. Das D, Sengupta M, Basu K, Tirkey M, Datta C, Chatterjee U. J Cytol; 2018 Jun 01; 35(3):153-158. PubMed ID: 30089944 [Abstract] [Full Text] [Related]
6. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H]. Wu Y, Zhao J, Hu J, Wu XW, Zhu LR. Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267 [Abstract] [Full Text] [Related]
7. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Int J Med Sci; 2013 Nov 25; 10(12):1602-7. PubMed ID: 24151431 [Abstract] [Full Text] [Related]
8. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Longatto Filho A, Utagawa ML, Shirata NK, Pereira SM, Namiyama GM, Kanamura CT, Santos Gda C, de Oliveira MA, Wakamatsu A, Nonogaki S, Roteli-Martins C, di Loreto C, Mattosinho de Castro Ferraz Mda G, Maeda MY, Alves VA, Syrjänen K. Int J Gynecol Pathol; 2005 Apr 25; 24(2):118-24. PubMed ID: 15782067 [Abstract] [Full Text] [Related]
9. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL. Possati-Resende JC, Fregnani JH, Kerr LM, Mauad EC, Longatto-Filho A, Scapulatempo-Neto C. PLoS One; 2015 Apr 25; 10(7):e0134445. PubMed ID: 26230097 [Abstract] [Full Text] [Related]
10. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests. Toll AD, Kelly D, Maleki Z. Diagn Cytopathol; 2014 Jul 25; 42(7):576-81. PubMed ID: 24288264 [Abstract] [Full Text] [Related]
11. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer]. Rokita W, Skawiński D, Zmelonek-Znamirowska A, Kedzia W, Karowicz-Bilińska A, Spaczyński R, Spaczyński M. Ginekol Pol; 2012 Nov 25; 83(11):822-6. PubMed ID: 23379189 [Abstract] [Full Text] [Related]
12. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. Nieh S, Chen SF, Chu TY, Lai HC, Fu E. Gynecol Oncol; 2003 Oct 25; 91(1):201-8. PubMed ID: 14529682 [Abstract] [Full Text] [Related]
13. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions. Zhang R, Ge X, You K, Guo Y, Guo H, Wang Y, Geng L. J Obstet Gynaecol Res; 2018 Nov 25; 44(11):2077-2084. PubMed ID: 30094887 [Abstract] [Full Text] [Related]
14. Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases. Ucak R, Dilbaz OF, Polat N. Acta Cytol; 2024 Nov 25; 68(1):54-59. PubMed ID: 38320537 [Abstract] [Full Text] [Related]
16. Evaluation of P16/Ki67 (CINtecPlus) and L1-capsid compared with HPV-genotyping in cervical cytology in women ≥35 years old focusing on patients with atypical squamous cells of undetermined significance. Abbas M, Erduran I, De Jonge J, Bettendorf O. Oncol Lett; 2022 Jul 25; 24(1):242. PubMed ID: 35720497 [Abstract] [Full Text] [Related]
18. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute. Yang J, Nolte FS, Chajewski OS, Lindsey KG, Houser PM, Pellicier J, Wang Q, Ehsani L. Diagn Cytopathol; 2018 Jan 25; 46(1):22-27. PubMed ID: 29048733 [Abstract] [Full Text] [Related]
19. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province]. Błońska E, Knapp PA. Ginekol Pol; 2013 Aug 25; 84(8):691-5. PubMed ID: 24191502 [Abstract] [Full Text] [Related]
20. Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining. Negri G, Moretto G, Menia E, Vittadello F, Kasal A, Mian C, Egarter-Vigl E. J Clin Pathol; 2006 Aug 25; 59(8):827-30. PubMed ID: 16467166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]